vinblastine has been researched along with 2-amino-3-cyano-7-(dimethylamino)-4-(3-methoxy-4,5-methylenedioxyphenyl)-4h-chromene in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Attardo, G; Blais, C; Bouffard, D; Cai, SX; Denis, R; Drewe, J; Gourdeau, H; Herich, J; Jia, S; Jiang, S; Kasibhatla, S; Kemnitzer, W; Labreque, D; Lamothe, S; Meerovitch, K; Rej, R; Storer, R; Tseng, B; Wang, Y; Zhang, H; Zhao, J | 1 |
1 other study(ies) available for vinblastine and 2-amino-3-cyano-7-(dimethylamino)-4-(3-methoxy-4,5-methylenedioxyphenyl)-4h-chromene
| Article | Year |
|---|---|
Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group.
Topics: Antineoplastic Agents; Apoptosis; Benzopyrans; Biopolymers; Caspases; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Dioxoles; Drug Screening Assays, Antitumor; Enzyme Activation; Humans; Poly(ADP-ribose) Polymerases; Structure-Activity Relationship; Tubulin | 2004 |